Nuvo Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NUVO PHARMS
NUVO PHARMS has twelve approved drugs.
There are four US patents protecting NUVO PHARMS drugs.
Summary for Nuvo Pharms
| US Patents: | 4 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 12 |
Drugs and US Patents for Nuvo Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuvo Pharms Inc | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 206105-001 | Oct 28, 2016 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nuvo Pharms Inc | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 207118-001 | Oct 28, 2016 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nuvo Pharms Inc | NAPROXEN | naproxen | TABLET, DELAYED RELEASE;ORAL | 091432-001 | Sep 19, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nuvo Pharms Inc | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 020947-001 | Nov 4, 2009 | DISCN | Yes | No | 8,546,450 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nuvo Pharms | NUVIGIL | armodafinil | TABLET;ORAL | 021875-002 | Mar 26, 2009 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Nuvo Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Nuvo Pharms | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | 4,177,290 | ⤷ Start Trial |
| Nuvo Pharms | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | 5,618,845 | ⤷ Start Trial |
| Nuvo Pharms | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | 4,177,290 | ⤷ Start Trial |
| Nuvo Pharms | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | 5,618,845 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for NUVO PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 100 mg and 200 mg | ➤ Subscribe | 2009-09-11 |
| ➤ Subscribe | Topical Solution | 2.0% | ➤ Subscribe | 2014-06-03 |
| ➤ Subscribe | Tablets | 50 mg, 150 mg and 250 mg | ➤ Subscribe | 2009-07-24 |
| ➤ Subscribe | Topical Solution | 1.5% | ➤ Subscribe | 2012-07-11 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
